Scully Mary-Frances

Idioma: Ingles.
Referencias bibliográficas: 10
Paginas: 309-312
Archivo PDF: 167.68 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kohler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L; Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011;9:1404-1406.

2. Schroeder V, Kohler HP. Factor XIII: structure and function. Semin Thromb Hemost. 2016;42:422-428.

3. Aleman MM, Byrnes JR, Wang JG, Tran R, Lam WA, Di Paola J et al. Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest. 2014;124:3509-3600.

4. Dickneite G. Coagulation factor XIII: a multifunctional transglutamase with clinical potential ina range of conditions. Thromb Haemost. 2015;113:686-697.

5. Peyvandi F. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders; results from the European network of rare bleeding disorders. J Thromb Haemost. 2012;10:615-621.

6. De Jager T. The burden and managemnet of FXIII deficiency. Haemophilia. 2014;20:733-740.

7. Hsu P. Factor XIII assays and associated problems for laboratory diagnosis of factor XII deficiency: an analysis of international proficiency testing results. Semin Thromb Hemost. 2014;40:232-238.

8. Dorgalaleh A. Guidelines for laboratory diagnosis of factor XIII deficiency. Blood Coagul Fibrinolysis. 2016;27:361-364.

9. Lassila R. Clinical use of factor XIII concentrates. Semin Thromb Hemost. 2016;42:440-444.

10. Karkouti K. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-contolled, multicenter clinical trial. J Thorac Cardiovasc Surg. 2013;146:927-939.